These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35865252)

  • 1. From 15 Minutes to 15 Seconds: How the Delta Variant Changed the Risk of Exposure to COVID-19. A Comparative Epidemiological Investigation Using Community Mobility Data From the Metropolitan Area of Genoa, Italy.
    Oliva C; Favato G
    Front Public Health; 2022; 10():872698. PubMed ID: 35865252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Exposure to COVID-19: Visit Duration Data Can Inform Our Daily Activities Choices: An Epidemiological Investigation Using Community Mobility Data from the Metropolitan Area of Genoa, Italy.
    Oliva C; Favato G
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2.
    Chun JY; Jeong H; Kim Y
    JAMA Netw Open; 2022 Mar; 5(3):e223064. PubMed ID: 35302625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of social distancing on early SARS-CoV-2 transmission in the United States.
    Sanchez JN; Reyes GA; Martínez-López B; Johnson CK
    Zoonoses Public Health; 2022 Sep; 69(6):746-756. PubMed ID: 35048530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture.
    Luzi L; Carruba M; Crialesi R; Da Empoli S; Dagani R; Lovati E; Nicolucci A; Berra CC; Cipponeri E; Vaccaro K; Lenzi A
    Acta Diabetol; 2021 Jul; 58(7):919-927. PubMed ID: 33740123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study.
    Schmidt M; Hajage D; Landoll M; Pequignot B; Langouet E; Amalric M; Mekontso-Dessap A; Chiscano-Camon L; Surman K; Finnerty D; Santa-Teresa P; Arcadipane A; Millán P; Roncon-Albuquerque R; Blandino-Ortiz A; Blanco-Schweizer P; Ricart P; Gimeno-Costa R; Albacete CL; Fortuna P; Schellongowski P; Dauwe D; Winiszewski H; Kimmoun A; Levy B; Hermans G; Grasselli G; Lebreton G; Guervilly C; Martucci G; Karagiannidis C; Riera J; Combes A;
    Lancet Respir Med; 2023 Feb; 11(2):163-175. PubMed ID: 36640786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unintended consequence of COVID-19 immunity passports-quasi-experimental evidence of moral hazard observed after implementing the domestic Green Pass policy during the second wave of the COVID-19 pandemic in Italy.
    Oliva C
    Front Public Health; 2024; 12():1345119. PubMed ID: 38694983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
    Trobajo-Sanmartín C; Martínez-Baz I; Miqueleiz A; Fernández-Huerta M; Burgui C; Casado I; Baigorría F; Navascués A; Castilla J; Ezpeleta C
    Microbiol Spectr; 2022 Apr; 10(2):e0000822. PubMed ID: 35412379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada.
    Chan YLE; Irvine MA; Prystajecky N; Sbihi H; Taylor M; Joffres Y; Schertzer A; Rose C; Dyson L; Hill EM; Tildesley M; Tyson JR; Hoang LMN; Galanis E
    Emerg Infect Dis; 2023 Oct; 29(10):1999-2007. PubMed ID: 37640374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland.
    Kerr S; Vasileiou E; Robertson C; Sheikh A
    J Glob Health; 2022 Jul; 12():05025. PubMed ID: 35802764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
    Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination.
    Yang W; Shaman J
    J R Soc Interface; 2022 Jun; 19(191):20210900. PubMed ID: 35670221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic heterogeneity of the epidemiological impact of the COVID-19 pandemic in Italy using a socioeconomic proxy-based classification of the national territory.
    Petrelli A; Ventura M; Di Napoli A; Mateo-Urdiales A; Pezzotti P; Fabiani M
    Front Public Health; 2023; 11():1143189. PubMed ID: 37151598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal strategies for vaccination and social distancing in a game-theoretic epidemiologic model.
    Choi W; Shim E
    J Theor Biol; 2020 Nov; 505():110422. PubMed ID: 32717195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effectiveness of Community-based Social Distancing for Mitigating the Spread of the COVID-19 Pandemic in Turkey.
    Durmuş H; Gökler ME; Metintaş S
    J Prev Med Public Health; 2020 Nov; 53(6):397-404. PubMed ID: 33296579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
    Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
    Petrone D; Mateo-Urdiales A; Sacco C; Riccardo F; Bella A; Ambrosio L; Lo Presti A; Di Martino A; Ceccarelli E; Del Manso M; Fabiani M; Stefanelli P; Pezzotti P; Palamara A;
    Int J Infect Dis; 2023 Apr; 129():135-141. PubMed ID: 36708869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing social distancing policies for the COVID-19 pandemic: A probabilistic model predictive control approach.
    Armaou A; Katch B; Russo L; Siettos C
    Math Biosci Eng; 2022 Jun; 19(9):8804-8832. PubMed ID: 35942737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.